bendroflumethiazide has been researched along with atrial natriuretic factor in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Peuhkurinen, K; Risteli, J; Ruskoaho, H; Tokola, H; Uusimaa, P; Vuolteenaho, O; Ylitalo, A | 1 |
| Navar, LG; Pandey, KN; Zhao, D | 1 |
2 other study(ies) available for bendroflumethiazide and atrial natriuretic factor
| Article | Year |
|---|---|
Vasoactive peptides and procollagen propeptides in patients with hypertension in relation to cardiac hypertrophy and diastolic heart failure: design of the study and patient characteristics.
Topics: Amlodipine; Antihypertensive Agents; Atenolol; Atrial Natriuretic Factor; Bendroflumethiazide; Cardiomegaly; Endothelin-1; Female; Heart Failure; Humans; Hypertension; Male; Middle Aged; Natriuretic Peptide, Brain; Perindopril; Procollagen; Randomized Controlled Trials as Topic | 2001 |
ANP-mediated inhibition of distal nephron fractional sodium reabsorption in wild-type and mice overexpressing natriuretic peptide receptor.
Topics: Absorption; Amiloride; Animals; Atrial Natriuretic Factor; Bendroflumethiazide; Blood Pressure; Diuretics; Dose-Response Relationship, Drug; Glomerular Filtration Rate; Kidney Tubules, Distal; Male; Mice; Mice, Inbred C57BL; Models, Animal; Receptors, Atrial Natriuretic Factor; Sodium | 2010 |